Kozo Kataoka

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer

Daisuke Kotani, Eiji Oki, Yoshiaki Nakamura et al. · Nature Medicine · 2023 · 430 citations · Full text

Surgical Oncology, Oncology, Cancer Epidemiology +15

Prognostic Impact of Postoperative Morbidity After Esophagectomy for Esophageal Cancer

Kozo Kataoka, Hiroya Takeuchi, Junki Mizusawa et al. · Annals of Surgery · 2016 · 212 citations

ctDNA-based molecular residual disease and survival in resectable colorectal cancer

Yoshiaki Nakamura, Jun Watanabe, Naoya Akazawa et al. · Nature Medicine · 2024 · 132 citations · Full text

Interim Analysis, Prognostic Biomarkers, Surgical Oncology +14

A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409

Kozo Kataoka, Hiroya Takeuchi, Junki Mizusawa et al. · Japanese Journal of Clinical Oncology · 2016 · 73 citations · Full text

A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study)

Kozo Kataoka, Masanori Tokunaga, Junki Mizusawa et al. · Japanese Journal of Clinical Oncology · 2015 · 46 citations · Full text

Systemic Chemotherapy, Surgical Oncology, Gastroenterology +17